May 31, 2022
BioSkryb Genomics Launches ResolveOME Early Access Program for Full Genome and Transcriptome Amplification from a Single Cell, in Conjunction with Its Innovative Bioinformatics Platform, BaseJumper
BioSkryb Genomics Launches ResolveOME Early Access Program for Full Genome and Transcriptome Amplification from a Single Cell, in Conjunction with Its Innovative Bioinformatics Platform, BaseJumperTM BioSkryb launches an exclusive Early Access Program at AGBT 2022 for ResolveOME and BaseJumper, a bioinformatics platform to accelerate single-cell exploration The company also...
February 9, 2022
BioSkryb Genomics and ALS Automated Lab Solutions GmbH Sign U.S. Distribution Agreement to Power Unprecedented Single Cell Spatial Genomics
BioSkryb Genomics and ALS Automated Lab Solutions GmbH Sign U.S. Distribution Agreement to Power Unprecedented Single Cell Spatial Genomics The agreement combines industry-leading technologies, enabling single cell selection and genome sequencing, and supports the development of intact tissue sample analysis Together these technologies are designed to deliver breakthrough insights...
October 12, 2021
BioSkryb Completes Move into New Global Headquarters in Durham, N.C.
BioSkryb Completes Move into New Global Headquarters in Durham, N.C. Move supports company’s multi-year strategic growth initiative; advances retention, attraction, and expansion of the team; enhances the ability to serve customers; and demonstrates Company’s commitment to the region DURHAM, N.C., October 12, 2021 – BioSkryb Genomics, Inc., today announced...
August 16, 2021
Meet BioSkryb’s New Commercial Team Members Providing Customer Care and Technical Support
Meet BioSkryb’s New Commercial Team Members We are excited to welcome three new team members who bring deep scientific knowledge as well as technical experience in supporting researcher needs in applying new genomic and molecular biology solutions. “Just as we know each cell is unique, so are our people,”...
August 4, 2021
In-depth empowerment and innovation! 2021 MGI & IDG Capital Life and Health Acceleration Camp officially opens
July 31 – Huatai Zhi made (MGI), IDG investment Innovation Institute and Blue Rainbow Life Sciences Accelerator jointly organized by the MGI & IDG capital accelerated life and health business (hereinafter referred to as “accelerated Camp”) in the Nanshan District, Shenzhen, IDG Capital Innovation the Investment Research Institute officially...
June 30, 2021
BioSkryb Appoints Gary Harton, Ph.D., Chief Scientific Officer
BioSkryb Appoints Gary Harton, Ph.D., Chief Scientific Officer DURHAM, N.C., June 30, 2021 — BioSkryb, Inc., today announced the expansion of the company’s leadership team with the appointment of Gary Harton, Ph.D., as Chief Scientific Officer. He has more than 30 years of experience in single cell diagnostic product...
April 22, 2021
BioSkryb Appoints Sean Keohane Senior Vice President of Commercial Operations
DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb, Inc., today announced the expansion of the company’s leadership team with the appointment of Sean Keohane as Senior Vice President of Commercial Operations. Keohane has more than 25 years of experience in life science product commercialization, with demonstrated success in building strong teams and implementing strategic...
March 10, 2021
Top 10 BioTech Industry Trends & Innovations in 2021
The BioTech industry is adopting trends like artificial intelligence (AI), data analytics, and automation to optimize production. Consequently, there has been a rise in consumer BioTech or BioTech products targeted directly at customers instead of biopharma or healthcare businesses. While the industry largely still focuses on medicine, startups are...
March 2, 2021
BioSkryb Announces the Winners of Its Grant Program to Aid Research Using Primary Template-directed Amplification Technology
DURHAM, N.C.–(BUSINESS WIRE)–Today, at the Advances in Genome Biology and Technology (AGBT) 2021 General Meeting held virtually, BioSkryb, Inc., a developer of genomic amplification technologies, announced the winners of a research grant program sponsored by the company. The grant program was created to accelerate innovation of single-cell genomic studies using...
December 10, 2020
BioSkryb Announces Research Grants to Access Breakthrough Single-Cell Whole Genome Amplification Technologies
DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb, Inc., a developer of genomic amplification technologies, today announced the launch of a research grant program sponsored by the company to accelerate innovation of single-cell genomic studies using its primary template-directed amplification (PTA) technology, now commercially available as the ResolveDNA™ suite of products. The program will...